欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0122/001
药品名称Co-Lisinomyl
活性成分
    • hydrochlorothiazide 12.5 mg
    • lisinopril dihydrate 10.0 mg
剂型Tablet
上市许可持有人Mylan Ireland Limited, Newenham Court, Northern Cross, Malahide Road, Dublin 17, Ireland
参考成员国 - 产品名称Malta (MT)
Co-Lisinomyl 10/12.5mg tablets
互认成员国 - 产品名称
    许可日期2011/10/04
    最近更新日期2022/07/25
    药物ATC编码
      • C09BA03 lisinopril and diuretics
    申请类型
    • TypeLevel1:Abridged
    • TypeLevel2:Initial Application
    • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase